Detalhe da pesquisa
1.
Targeting the IL-2 inducible kinase in melanoma; a phase 2 study of ibrutinib in systemic treatment-refractory distant metastatic cutaneous melanoma: preclinical rationale, biology, and clinical activity (NCI9922).
Melanoma Res
; 31(2): 162-172, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33661190
2.
Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
J Invest Dermatol
; 139(6): 1349-1361, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30529013
3.
IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.
Clin Cancer Res
; 21(9): 2167-76, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25934889
4.
Genome-wide regulatory analysis using en masse nuclear run-ons and ribonomic profiling with autoimmune sera.
Gene
; 317(1-2): 79-87, 2003 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-14604794
5.
Mechanisms of chromosomal instability in melanoma.
Environ Mol Mutagen
; 55(6): 457-71, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24616037
6.
Targeted next generation sequencing identifies clinically actionable mutations in patients with melanoma.
Pigment Cell Melanoma Res
; 27(4): 653-63, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24628946
7.
DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.
Pigment Cell Melanoma Res
; 27(6): 1097-105, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24986547
8.
MERTK receptor tyrosine kinase is a therapeutic target in melanoma.
J Clin Invest
; 123(5): 2257-67, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23585477
9.
Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays.
Methods
; 26(2): 191-8, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12054896